Suppliers / Ranbaxy Malaysia Sdn Bhd

Ranbaxy Malaysia Sdn Bhd

Malaysia Updated 9 July 2026

Ranbaxy Malaysia Sdn Bhd is a finished-dose manufacturer based in Malaysia. It appears in 177 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), HSA (SG) and ANPP (DZ).

0
active US DMFs
0
valid CEPs
0
registered plants
177
filings across 3 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 110 None
HSA (SG) 65 None
ANPP (DZ) 2 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Comparing suppliers?

Choose your molecules and target markets. Ranbaxy Malaysia Sdn Bhd comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability